Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
220 participants
OBSERVATIONAL
2022-10-20
2024-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
NCT04882085
Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections
NCT05258851
Relationship Between Different Administration Regimens of Ceftazidime/Avibactam and Clinical Outcomes
NCT06528028
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
NCT01644643
EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.
NCT05148702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ceftazidime avibactam group
Receive ≥1 dose of ceftazidime avibactam in routine practice; Aged ≥ 18 years old at the time of the informed consent signature.
ceftazidime avibactam group
Non-Interventional Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ceftazidime avibactam group
Non-Interventional Study
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ≥ 18 years old at the time of the informed consent signature.
Exclusion Criteria
* Pregnant women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Beijing Tsinghua Changgung Hospital
Beijing, , China
Xiangya Hospital Central South University
Changsha, , China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, , China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, , China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, , China
The First affiliated Hospital of Anhui Medical University
Hefei, , China
The First Affiliated Hospital of Nanchang University
Nanchang, , China
Zhongda Hospital Southeast University
Nanjing, , China
The Affiliated People's Hospital of Ningbo University
Ningbo, , China
Shanghai Tenth People's Hospital
Shanghai, , China
The Second People's Hospital of Hebei Medical University
Shijiazhuang, , China
The Third Hospital of Hebei Medical University
Shijiazhuang, , China
The First Affiliated Hospital of Soochow University
Suzhou, , China
Tianjin Medical University General Hospital
Tianjing, , China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, , China
Henan Provincial People's Hospital
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C3591037
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.